ストックスクリーナーアプリを入手
127.69
0.16%
-0.20
前日終値:
$127.89
開ける：
$127.55
24時間の取引高:
3.20M
Relative Volume:
0.90
時価総額：
$56.27B
収益：
$9.40B
当期純損益:
$2.65B
株価収益率:
21.51
EPS:
5.935
ネットキャッシュフロー:
$2.24B
1週間 パフォーマンス:
+9.06%
1か月 パフォーマンス:
-12.51%
6か月 パフォーマンス:
-21.46%
1年 パフォーマンス:
-27.32%
1日の値動き範囲:
$126.93
$129.06
1週間の範囲:
$115.71
$129.06
52週間の値動き範囲:
$115.25
$181.85
Zoetis Inc Stock (ZTS) Company Profile
ZTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
127.69 | 56.36B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.52 | 45.81B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.32 | 28.67B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
488.43 | 20.92B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | BTIG Research | Buy |
| 2024-01-12 | 繰り返されました | Stifel | Buy |
| 2023-12-19 | 再開されました | Jefferies | Buy |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2022-07-12 | 開始されました | Piper Sandler | Overweight |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-03-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 開始されました | Atlantic Equities | Overweight |
| 2020-08-14 | アップグレード | Edward Jones | Hold → Buy |
| 2020-08-12 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 開始されました | Jefferies | Buy |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-09-09 | 開始されました | Goldman | Buy |
| 2019-07-01 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 開始されました | Barclays | Overweight |
| 2019-05-23 | 開始されました | Guggenheim | Buy |
| 2019-05-03 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-03-04 | アップグレード | Stifel | Hold → Buy |
| 2019-01-23 | 開始されました | UBS | Neutral |
| 2018-10-15 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-08-22 | ダウングレード | Stifel | Buy → Hold |
| 2018-08-03 | 繰り返されました | Stifel | Buy |
| 2018-04-19 | 繰り返されました | Citigroup | Buy |
| 2018-03-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 繰り返されました | Stifel | Buy |
| 2018-01-04 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Zoetis Inc (ZTS) 最新ニュース
Zoetis (ZTS) Gains EU Approval for Lenivia in Canine Osteoarthri - GuruFocus
Zoetis receives European approval for Lenivia for osteoarthritis in dogs (ZTS:NYSE) - Seeking Alpha
Zoetis (ZTS) Gains EU Approval for Canine Osteoarthritis Therapy Lenivia - GuruFocus
European Commission approves Zoetis’ three-month OA pain therapy for dogs - Investing.com
Zoetis receives European Commission marketing authorization for Lenivia (izenivetmab) to reduce pain associated with osteoarthritis (OA) in dogs - MarketScreener
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - MarketScreener
Zoetis (NYSE: ZTS) receives EU marketing authorization for Lenivia OA pain therapy - Stock Titan
Stifel Lowers Zoetis (ZTS) PT to $130, Maintains 'Hold' Due to Aggressive 2026 Revenue Outlook - Finviz
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Zoetis Stock Underperforming the Dow? - Yahoo Finance
Stifel Lowers Zoetis (ZTS) PT to $130, Maintains ‘Hold’ Due to Aggressive 2026 Revenue Outlook - MSN
Paul Harris' Top Picks: FirstService, Zoetis & Adobe - BNN Bloomberg
Top Animal Health Stocks: Elanco Leads with Innovation, Zoetis Faces Headwinds - Investing.com Canada
Cash per share of Zoetis, Inc. Class A – MIL:1ZTS - TradingView
Keybanc Initiates Coverage of Zoetis (ZTS) with Sector Weight Recommendation - MSN
Does the Recent 30% Drop Make Zoetis a Bargain Opportunity in 2025? - Yahoo Finance
Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know - Finviz
Zoetis Inc. Class A (ZTS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
ZTS (Zoetis) Issuance of Stock : $0 Mil (TTM As of Sep. 2025) - GuruFocus
Zoetis (ZTS) Receives New Analyst Rating from Keybanc | ZTS Stoc - GuruFocus
Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space - Seeking Alpha
Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - inkl
KeyBanc initiates coverage on Zoetis stock with Sector Weight rating By Investing.com - Investing.com South Africa
KeyBanc initiates coverage on Zoetis stock with Sector Weight rating - Investing.com
Zoetis (ZTS) Coverage Initiated with Sector Weight Rating by Key - GuruFocus
Zoetis, Wrangler NFR continue partnership to strengthen equine biosecurity - Equus Magazine
A Look Into Zoetis Inc's Price Over Earnings - Benzinga
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference - The AI Journal
Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Published on: 2025-11-20 01:52:12 - newser.com
Can Zoetis Inc. Class stock deliver double digit returns2025 Price Momentum & Short-Term Trading Alerts - newser.com
How supply shortages influence Zoetis Inc. Class stockJuly 2025 Technicals & Verified Momentum Stock Alerts - newser.com
Is Zoetis Inc. meeting your algorithmic filter criteria2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
Published on: 2025-11-19 16:55:31 - newser.com
Is Zoetis Inc. Class stock a buy on weakness2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
Why Zoetis Inc. Class stock is a strong analyst pickTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
Technical signs of recovery in Zoetis Inc.Gap Up & Low Risk Entry Point Guides - newser.com
Is Zoetis Inc. Class stock cheap by valuation metricsPortfolio Performance Report & Safe Capital Growth Plans - newser.com
Zoetis to Host Innovation Webcast - The Globe and Mail
How big funds are accumulating Zoetis Inc. (ZOE) stock2025 Price Targets & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 02:42:09 - newser.com
Can Zoetis Inc. stock hit record highs againJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Candlestick signals on Zoetis Inc. stock today2025 Growth vs Value & Technical Pattern Based Buy Signals - newser.com
Zoetis (ZTS): Analyst Stifel Maintains Hold, Lowers Price Target to $130 | ZTS Stock News - GuruFocus
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsStop Loss & Weekly Top Gainers Trade List - newser.com
Published on: 2025-11-18 16:20:31 - newser.com
Zoetis down despite Q1 beats, boosting 2025 guidance - MSN
Zoetis stock hits 52-week low at $117.26 By Investing.com - Investing.com Australia
Zoetis Inc (ZTS) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.61%
大文字化:
|
ボリューム (24 時間):